Cargando…

Four-dimensional quantitative analysis using FDG-PET in clinical oncology

Positron emission tomography (PET) with F-18 fluorodeoxyglucose (FDG) has been commonly used in many oncological areas. High-resolution PET permits a three-dimensional analysis of FDG distributions on various lesions in vivo, which can be applied for tissue characterization, risk analysis, and treat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tamaki, Nagara, Hirata, Kenji, Kotani, Tomoya, Nakai, Yoshitomo, Matsushima, Shigenori, Yamada, Kei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Nature Singapore 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366296/ https://www.ncbi.nlm.nih.gov/pubmed/36947283 http://dx.doi.org/10.1007/s11604-023-01411-4

Ejemplares similares

Quantitative FDG PET Assessment for Oncology Therapy
por: Hirata, Kenji, et al.
Publicado: (2021)

FDG-PET Findings of Intraductal Oncocytic Papillary Neoplasms of the Pancreas: Two Case Reports
por: Kato, Takashi, et al.
Publicado: (2012)

Reproducibility and uptake time dependency of volume-based parameters on FDG-PET for lung cancer
por: Kitao, Tomoka, et al.
Publicado: (2016)

A Semi-Automated Technique Determining the Liver Standardized Uptake Value Reference for Tumor Delineation in FDG PET-CT
por: Hirata, Kenji, et al.
Publicado: (2014)

The usefulness of (18)F-FDG PET/CT for assessing methotrexate-associated lymphoproliferative disorder (MTX-LPD)
por: Watanabe, Shiro, et al.
Publicado: (2016)

Voxel based comparison and texture analysis of (18)F-FDG and (18)F-FMISO PET of patients with head-and-neck cancer
por: Kroenke, Markus, et al.
Publicado: (2019)

Quantitative techniques in (18)FDG PET scanning in oncology
por: Castell, F, et al.
Publicado: (2008)

Combination of FDG-PET and FMISO-PET as a treatment strategy for patients undergoing early-stage NSCLC stereotactic radiotherapy
por: Watanabe, Shiro, et al.
Publicado: (2019)

Partial volume correction strategies for quantitative FDG PET in oncology
por: Hoetjes, Nikie J., et al.
Publicado: (2010)

Quantitative approaches of dynamic FDG-PET and PET/CT studies (dPET/CT) for the evaluation of oncological patients
por: Dimitrakopoulou-Strauss, Antonia, et al.
Publicado: (2012)

Application of FDG-PET/CT in Radiation Oncology
por: Li, Jun, et al.
Publicado: (2013)

Appropriateness criteria of FDG PET/CT in oncology
por: Agrawal, Archi, et al.
Publicado: (2015)

Renal Mucinous Tubular and Spindle Cell Carcinoma Shows a High Uptake on (18)F-FDG PET/CT
por: Furuya, Sho, et al.
Publicado: (2017)

(18)F-FDG PET/CT Imaging In Oncology
por: Almuhaideb, Ahmad, et al.
Publicado: (2011)

Methodological considerations in quantification of oncological FDG PET studies
por: Vriens, Dennis, et al.
Publicado: (2009)

How We Read Oncologic FDG PET/CT
por: Hofman, Michael S., et al.
Publicado: (2016)

The effects of 18-h fasting with low-carbohydrate diet preparation on suppressed physiological myocardial (18)F-fluorodeoxyglucose (FDG) uptake and possible minimal effects of unfractionated heparin use in patients with suspected cardiac involvement sarcoidosis
por: Manabe, Osamu, et al.
Publicado: (2015)

Present and future roles of FDG-PET/CT imaging in the management of gastrointestinal cancer: an update
por: Kitajima, Kazuhiro, et al.
Publicado: (2017)

Integrated (18)FDG PET/CT: Utility and Applications in Clinical Oncology
por: Pinilla, Inmaculada, et al.
Publicado: (2008)

FDG-PET/CT pitfalls in oncological head and neck imaging
por: Purohit, Bela S., et al.
Publicado: (2014)

FDG-PET/CT pitfalls in gynecological and genitourinary oncological imaging
por: Lakhani, A, et al.
Publicado: (2015)

The Roles of Hypoxia Imaging Using (18)F-Fluoromisonidazole Positron Emission Tomography in Glioma Treatment
por: Hirata, Kenji, et al.
Publicado: (2019)

Biodistribution and radiation dosimetry of the novel hypoxia PET probe [(18)F]DiFA and comparison with [(18)F]FMISO
por: Watanabe, Shiro, et al.
Publicado: (2019)

Growing applications of FDG PET-CT imaging in non-oncologic conditions
por: Zhuang, Hongming, et al.
Publicado: (2015)

Non-FDG PET/CT in Diagnostic Oncology: a pictorial review
por: Giammarile, Francesco, et al.
Publicado: (2019)

Early prediction of lenvatinib treatment efficacy by using (18)F-FDG PET/CT in patients with unresectable or advanced thyroid carcinoma that is refractory to radioiodine treatment: a protocol for a non-randomized single-arm multicenter observational study
por: Takeuchi, Satoshi, et al.
Publicado: (2018)

ACT-07 Clinical Trials of 11C-Methionine PET for brain tumors
por: Yamaguchi, Shigeru, et al.
Publicado: (2020)

Change in (18)F-Fluoromisonidazole PET Is an Early Predictor of the Prognosis in the Patients with Recurrent High-Grade Glioma Receiving Bevacizumab Treatment
por: Yamaguchi, Shigeru, et al.
Publicado: (2016)

Diagnostic accuracy for the epileptogenic zone detection in focal epilepsy could be higher in FDG-PET/MRI than in FDG-PET/CT
por: Kikuchi, Kazufumi, et al.
Publicado: (2020)

Quantitative and visual analyses of the effect of activity reduction on image metrics and quality in 18F-FDG PET/MRI in pediatric oncology
por: AYDOS, Uğuray, et al.
Publicado: (2022)

PET/CT scanning with 3D acquisition is feasible for quantifying myocardial blood flow when diagnosing coronary artery disease
por: Manabe, Osamu, et al.
Publicado: (2017)

The impact of infection and inflammation in oncologic (18)F-FDG PET/CT imaging
por: Rahman, W. Tania, et al.
Publicado: (2019)

A case series of FDG PET scan: hypometabolic lesions that matter in oncology
por: Chan, Tak Kwong, et al.
Publicado: (2023)

A Preliminary Study to Use SUVmax of FDG PET-CT as an Identifier of Lesion for Artificial Intelligence
por: Hirata, Kenji, et al.
Publicado: (2021)

MRI and FDG PET/CT Findings for Borderline Brenner Tumor of the Ovary: A Case Report and Literature Review
por: Matsutani, Hiroki, et al.
Publicado: (2020)

Variation in urinary excretion of FDG, yet another uncertainty in quantitative PET
por: Bach-Gansmo, Tore, et al.
Publicado: (2012)

Analysis and interpretation of dynamic FDG PET oncological studies using data reduction techniques
por: Pavlopoulos, Sotiris, et al.
Publicado: (2007)

Can the Efficacy of [(18)F]FDG-PET/CT in Clinical Oncology Be Enhanced by Screening Biomolecular Profiles?
por: O’Neill, Hazel, et al.
Publicado: (2019)

Comparison of primary target volumes delineated on four-dimensional CT and (18) F-FDG PET/CT of non-small-cell lung cancer
por: Duan, Yi-Li, et al.
Publicado: (2014)

FDG-PET in lymphoma
por: Meignan, Michel
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_sueh4sm1lntd9246hg1uolc1n2